+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Myelodysplastic Syndrome Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Acute Myeloid Leukemia Market Report 2025 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Multiple Myeloma Drugs Market Report 2025 - Product Thumbnail Image

Multiple Myeloma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hypercalcemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hypercalcemia Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 383 Pages
  • Global
From
From
From
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator